On November 25, 2025, Tyra Biosciences appointed Bhavesh Ashar as Chief Operating Officer, effective December 1, 2025, succeeding Daniel Bensen who becomes Chief Discovery Officer. Ashar's annual salary is set at $550,000 with a 40% annual bonus target and 300,000 stock options that vest over four years.